Related references
Note: Only part of the references are listed.Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
Jacqueline R. Center et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Placebo Adherence, Clinical Outcomes, and Mortality in the Women's Health Initiative Randomized Hormone Therapy Trials
Jeffrey R. Curtis et al.
MEDICAL CARE (2011)
Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study
P. N. Sambrook et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis
Lisa-Ann Fraser et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2011)
If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy
Jonathan D. Adachi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2011)
Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival
Pia Nimann Kannegaard et al.
AGE AND AGEING (2010)
Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
Patrick Haentjens et al.
ANNALS OF INTERNAL MEDICINE (2010)
Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Loss of life years after a hip fracture Effects of age and sex
Peter Vestergaard et al.
ACTA ORTHOPAEDICA (2009)
Effectiveness of bisphosphonate therapy in a community setting
Adrianne C. Feldstein et al.
BONE (2009)
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients
Daniele Santini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Increased Bone Resorption Is Associated With Higher Mortality in Community-Dwelling Men >= 50 Years of Age: The MINOS Study
Pawel Szulc et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles
L. D. Carbone et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
High bone turnover is an independent predictor of mortality in the frail elderly
PN Sambrook et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study
JJW Roche et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Mortality and morbidity associated with osteoporosis drug treatment following hip fracture
MW Cree et al.
OSTEOPOROSIS INTERNATIONAL (2003)
Share Paper
